Sickle cell disease, which is a group of inherited red blood cell disorders, affects approximately 100,000 people in the U.S., according to the Centers for Disease Control and Prevention.
Sep 10, 2021
0
6
Zolgensma—which treats spinal muscular atrophy, a rare genetic disease that damages nerve cells, leading to muscle decay—is currently the most expensive drug in the world. A one-time treatment of the life-saving drug ...
Sep 1, 2021
0
16
They're cancer patients. Transplant recipients. People with lupus, rheumatoid arthritis, HIV/AIDS, sickle cell disease, kidney failure and Crohn's disease. Plus millions of others who have conditions or take medications that ...
Aug 17, 2021
0
119
(HealthDay)—Sickle cell disease is associated with a fourfold increased risk for COVID-19-related hospitalization and a more than twofold increased risk for COVID-19-related death, according to a research letter published ...
Jul 29, 2021
0
35
(HealthDay)—For adults with sickle cell disease (SCD) with uncomplicated vaso-occlusive crises, outcomes are significantly better with treatment at an infusion center (IC) compared with an emergency department (ED), according ...
Jul 7, 2021
0
3
During the large second wave of the COVID-19 pandemic in fall 2020, pulmonologist and critical care provider Juan C. Rojas, MD, reflected on how disproportionately members of minority populations were being affected by the ...
Jul 2, 2021
0
3
New research published today in the journal Blood Advances finds that certain factors, such as a history of severe pain episodes and coexisting organ conditions, increase the risk of severe COVID-19 illness, including hospitalization, ...
Jul 1, 2021
0
3
It's been more than six months since Brandy Compton last landed in a hospital emergency room.
Jun 21, 2021
0
2
Sickle Cell Disease (SCD) is a genetically inherited group of red blood cell disorders. According to the CDC, an estimated 90,000 to 100,000 people in the United States live with this disease, and it disproportionately affects ...
Jun 3, 2021
0
1
Researchers at Children's Hospital of Philadelphia (CHOP) have developed a proof-of-concept treatment for blood disorders like sickle cell disease and beta-thalassemia that could raise hemoglobin levels by activating production ...
Jun 1, 2021
0
6
